TAMPA, Fla. , Oct. 20, 2022 /PRNewswire/ — The 5th Annual Neuropsychiatric and Psychedelics Drug Development Summit will be held in Boston, MA from October 31st to November 2nd. Dr. Jackie von Salm, Psilera Co-Founder and CSO, is speaking on “Investigating the Mechanism of Psychedelics and Psychedelic-Derivatives in CNS Disorders” and Dr. Chris Witowski, Psilera Co-Founder and CEO, will be on the…


Previous articleThe Interdisciplinary Conference on Psychedelic Research (ICPR)
Next articleatai Life Sciences Announces R&D Day Agenda